Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bares

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cognitive, Affective & Behavioral Neuroscience|December 29, 2012
ERPs and morphological processing: the N400 and semantic compositionDonna Coch, Jennifer Bares, Allison Landers
Hospital Pediatrics|February 9, 2017
Pain Control and Parent Mental Health Among Pediatric InpatientsAndrew Barnes, Ashley Tollefson, Patricia Hickey, et al.
JAAD Case Reports|February 17, 2017
Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographicJennifer Bares, Apphia Wang, Peter Pavlidakey, et al.
Journal of the American Academy of Dermatology|May 13, 2019
Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failedGrace Kimmel, Margot Chima, Hee Jin Kim, et al.
Allergy|August 30, 2021
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patientsEmma Guttman-Yassky, Yael Renert-Yuval, Jennifer Bares, et al.
Journal of the American Academy of Dermatology|July 7, 2019
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trialPeter W Hashim, Margot Chima, Hee J Kim, et al.
The British Journal of Dermatology|June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomesYael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot studyHee J Kim, Giselle K Singer, Ester Del Duca, et al.
Allergy|October 22, 2022
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areataYael Renert-Yuval, Ana B Pavel, Ester Del Duca, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cognitive, Affective & Behavioral Neuroscience|December 29, 2012
ERPs and morphological processing: the N400 and semantic compositionDonna Coch, Jennifer Bares, Allison Landers
Hospital Pediatrics|February 9, 2017
Pain Control and Parent Mental Health Among Pediatric InpatientsAndrew Barnes, Ashley Tollefson, Patricia Hickey, et al.
JAAD Case Reports|February 17, 2017
Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographicJennifer Bares, Apphia Wang, Peter Pavlidakey, et al.
Journal of the American Academy of Dermatology|May 13, 2019
Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failedGrace Kimmel, Margot Chima, Hee Jin Kim, et al.
Allergy|August 30, 2021
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patientsEmma Guttman-Yassky, Yael Renert-Yuval, Jennifer Bares, et al.
Journal of the American Academy of Dermatology|July 7, 2019
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trialPeter W Hashim, Margot Chima, Hee J Kim, et al.
The British Journal of Dermatology|June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomesYael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot studyHee J Kim, Giselle K Singer, Ester Del Duca, et al.
Allergy|October 22, 2022
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areataYael Renert-Yuval, Ana B Pavel, Ester Del Duca, et al.
Pageof 1